BATH & BODY WORKS INC

Bath & Body Works stock slumps 6.6% in mid‑September 2026, amid weak consumer‑discretionary markets. Investors weigh a 16.7% YTD drop, low P/E, and potential undervaluation.

Bath & Body Works shares fell to $18.61 on August 31, 2026, after a sharp drop from its 52‑week high. Investors weigh competition, consumer shifts and the brand’s strong heritage while the company seeks to regain confidence and growth.

Bath & Body Works Q2 2026: sales fell 2.3 % but EPS jumps to $0.62, driven by a $80 M tariff refund and cost cuts. New FY 2026 EPS guide $2.60‑$2.80 amid digital expansion and portfolio trim.

Investor alert: Bath & Body Works faces a March 16, 2026 deadline for a securities class action—learn how the lawsuit could hit the stock and what to do if you lost over $100k.

Bath & Body Works faces a mix of exciting PEEPS collaboration hype and analyst upside, but looming class‑action claims and unclear Amazon ties raise risks for investors.

Bath & Body Works faces a surge of investor‑legal action, with a March 16, 2026 class‑action deadline and multiple law firms urging shareholders to act—learn how to protect your stake.

Bath & Body Works Inc. stock hits $20.74, trading at 58% of its peak, amid 106,000 shares sold by Blueshift and steady consumer‑discretionary growth.

Bath & Body Works Inc. faces financial headwinds after adjusting its fiscal year 2025 outlook, leading to a 6.7% drop in its stock price and raising concerns about its future performance.

Bath & Body Works Inc. reported a mixed financial quarter, with a profit miss due to rising costs, but also continued sales growth and improved fiscal guidance.

Bath & Body Works Inc. reported a profit of $105 million in Q1 2025, exceeding expectations, and reaffirmed its outlook for the fiscal year despite navigating challenges in certain areas.